According to IMARC Group, the United States brain monitoring market size reached USD 1.78 Billion in 2025 and is projected to reach USD 3.11 Billion by 2034, growing at a CAGR of 6.13% during 2026-2034. Rising prevalence of neurological disorders such as epilepsy, Alzheimer's disease, Parkinson's disease, and stroke continues to drive demand for advanced brain monitoring technologies across hospitals and diagnostic centers nationwide.

United States Brain Monitoring Market Size and Forecast

The United States brain monitoring market encompasses a broad range of devices used to observe and measure brain activity, including electroencephalography (EEG), functional magnetic resonance imaging (fMRI), and magnetoencephalography (MEG) systems. These technologies are integral to diagnosing and managing neurological disorders, studying cognitive processes, and evaluating the impact of clinical interventions.

Growth through 2034 is being shaped by the integration of artificial intelligence and machine learning into monitoring platforms, rising R&D investment among device manufacturers, and an expanding geriatric population that is more susceptible to age-related neurological conditions. Together, these factors are fostering closer collaboration between healthcare providers, technology developers, and research institutions across the country.

Get Insights on the United States Brain Monitoring Market- Access the IMARC Sample Report: https://www.imarcgroup.com/united-states-brain-monitoring-market/requestsample

Key Trends

•        Growing Integration of Artificial Intelligence: AI and machine learning algorithms are increasingly embedded in monitoring devices, enhancing diagnostic accuracy and enabling faster, more reliable clinical assessments of neurological conditions.

•        Shift Toward Non-Invasive and Wearable Monitoring: Advancements in sensor miniaturization and wireless connectivity are enabling long-duration, real-world brain monitoring outside traditional hospital settings, extending diagnostic reach into homes and outpatient clinics.

•        Rising Burden of Neurological and Age-Related Disorders: An aging population combined with the increasing prevalence of epilepsy, dementia, and traumatic brain injury is sustaining strong long-term demand for continuous and periodic brain monitoring solutions.

United States Brain Monitoring Market Segmentation

IMARC Group's analysis categorizes the United States brain monitoring market across product type, procedure, application, and end user, providing forecasts at the country level for 2026-2034.

By Product Type:

•        Electroencephalography (EEG) Devices

•        Magnetoencephalography (MEG) Devices

•        Transcranial Doppler (TCD) Devices

•        Intracranial Pressure (ICP) Monitors

•        Cerebral Oximeters

•        Magnetic Resonance Imaging (MRI) Devices

•        Computerized Tomography (CT) Devices

•        Positron Emission Tomography (PET) Devices

•        Sleep Monitoring Devices

•        Electromyography (EMG) Devices

•        Accessories

By Procedure:

•        Invasive

•        Non-Invasive

By Application:

•        Parkinson's Disease

•        Traumatic Brain Injury (TBI)

•        Epilepsy

•        Dementia

•        Sleep Disorders

•        Others

By End User:

•        Hospitals

•        Diagnostic Centers

Regional Insights

The report provides a comprehensive analysis of the major regional markets across the United States, capturing variation in healthcare infrastructure, hospital density, and adoption of advanced diagnostic technologies.

•        Northeast: Benefits from a dense concentration of academic medical centers and neurology research institutions driving early adoption of advanced monitoring technologies.

•        Midwest: Supported by expanding hospital networks and growing investment in neurocritical care infrastructure.

•        South: Witnessing rapid growth in diagnostic center penetration alongside a rising elderly population base.

•        West: Driven by strong presence of medical device innovators and rising adoption of AI-enabled monitoring platforms.

Recent News and Developments

•        January 2026: Naox Technologies received the first-ever FDA 510(k) clearance for an in-ear electroencephalography device, Naox Link, enabling long-duration, real-world brain monitoring beyond traditional hospital environments for neurology, epilepsy, and sleep applications.

•        April 2026: Zeto received a third FDA 510(k) clearance for its New Wave EEG device, designed for outpatient and home use, aiming to address a persistent shortage of EEG technologists that has delayed patient follow-up care across the country.

Challenges

Despite favorable growth prospects, the market faces hurdles including a shortage of trained EEG technologists and neurologists, high costs associated with advanced imaging and monitoring equipment, and reimbursement complexities across diverse payer systems.

Stringent FDA regulatory pathways, while ensuring device safety, can also extend time-to-market for novel monitoring technologies, creating pressure on smaller innovators competing against established manufacturers with deeper regulatory resources.

Investment Opportunities

Substantial opportunities exist in wearable and in-ear EEG platforms, AI-enabled diagnostic software, and cloud-based remote monitoring infrastructure that extends care beyond hospital walls into home and outpatient settings.

Outlook

The United States brain monitoring market is expected to sustain steady growth through 2034, underpinned by demographic shifts, technological innovation, and expanding applications in critical and outpatient care settings.

Key Players

•        Nihon Kohden Corporation: A Tokyo-headquartered leader in medical electronics that exports to more than 120 countries, Nihon Kohden supplies widely used EEG systems and neurology patient monitoring solutions, including its Neurofax platform, supporting diagnosis of epilepsy and other brain disorders across U.S. hospitals and clinics.

•        Medtronic plc: A global medical technology leader with a strong neurology portfolio, Medtronic continues to advance closed-loop neuromonitoring and deep brain stimulation technologies, and has expanded partnerships to integrate brain monitoring capabilities into broader patient monitoring ecosystems.

Frequently Asked Questions

1. How big is the brain monitoring market in the United States?

The United States brain monitoring market was valued at USD 1.78 Billion in 2025.

2. What is the future outlook of the brain monitoring market in the United States?

The market is projected to grow at a CAGR of 6.13% during 2026-2034, reaching approximately USD 3.11 Billion by 2034.

3. What are the key factors driving the United States brain monitoring market?

Growth is driven by the rising prevalence of neurological disorders, growing demand for minimally invasive monitoring techniques, advancements in neuroimaging and diagnostic technologies, and increasing healthcare expenditure across hospitals and diagnostic centers.

4. Which product segment leads the United States brain monitoring market?

Electroencephalography (EEG) devices remain among the most widely adopted product types, reflecting their established role in diagnosing epilepsy, sleep disorders, and other neurological conditions.

Author IMARC Group 

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

United States: +1-201971-6302